Lisdexamfetamine for BED: How Effective Over the Long Term?
The Carlat Psychiatry Report, Volume 16, Number 4, April 2018
Robert T. Rubin, MD, PhD.
Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Lisdexamfetamine (Vyvanse) is an extended release amphetamine-based stimulant that is approved for both ADHD and binge eating disorder (BED).